BBC World Service: Why cancer patients are flying to China for treatment
BBC World Service looks at why some cancer patients are travelling to China for advanced care, including CAR-T access, cost differences, clinical-trial volume, and patient logistics.
Asia Specific · Jul 1, 2026
What this covers
- China is gaining attention as a destination for advanced cancer treatment, especially CAR-T.
- CAR-T modifies a patient's immune cells to identify and attack cancer cells.
- The episode discusses why treatment may be cheaper and faster in China than in many Western countries.
- It includes Amanda Harvey's perspective as an Australian patient and doctor who travelled to Shanghai after multiple myeloma treatment.
- Bloomberg Health reporter Karoline Kan adds context on China's CAR-T development, clinical trials, and medical-tourism potential.
Why we included it
This is useful background because it comes from an independent media source and focuses on the same questions international patients ask before contacting a hospital: access, cost, timing, patient logistics, and the limits of what one treatment can prove.
What it does not prove
This reference does not prove that any treatment is appropriate for a specific patient, that a hospital can accept a case, or that an outcome is guaranteed. It is context for further discussion with qualified physicians.
Key moments
Medical boundary
This external BBC World Service episode is provided for background information only. It is not medical advice, and it does not mean ChinaHospital endorses any specific treatment, hospital, trial, or outcome. Patients should consult qualified physicians before making treatment decisions.